Abstracts of papers and posters Meeting on Pharmaceutical Sciences

Autor: J. D. Vries, J. Zuidema, Trea A. Galiën, G. T. Werf, H. Wesseling, Herre Talsma, A. C. Eissens, Ilva Bommel, N. Stecher, C. M. Ree, M. Olling, B. Steffens, R. J. M. Hooff, K. S. Beuning, M. W. Lammers, W. I. Iwema Bakker, H. J. Haisma, D. A. Piers, A. N. Fransz, R. A. M. Kengen, P. Salomons, G. H. P. Wierik, Russell C. Coile, L. M. Bouter, Marco C. Stehouwer, J. Medema, J. G. W. Kosterink, W. N. E. Wolthuis, D. J. Touw, G. M. Visser, A. Dijk, D. R. A. Uges, Anke M. Trigtv, A. Knevelman, R. Stewart, H. Junginger, J. A. A. M. Kamps, H. E. Boddé, Jacobus Swart, J. R. Marler, Bruno H. Stricker, R. H. P. Smit, J. Biller, N. E. H. W. Hendrikx, Rein Vos, F. J. W. Mansvelt, S. S. N. Graaf, R. H. B. Meyboom, J. Hermans, W. Brand, E. J. F. Franssen, H. P. Adams, L. Leij, Hubert G. M. Leufkens, Ferd Sturmans, P. J. Reinhoud, I. H. Go, D. N. Reinhoudt, A. T. P. Skrabanja, J. W. F. Mil, M. M. W. B. Hendriks, H. S. Lau, T. Hultermans, A.J.M. Schoonen, R. Wolters, G. Storm, M. W. Versantvoort, L. J. Stokx, G. H. P. Koning, Albert Bakker, Anthonius Boer, J. Velden, B. A. Ruben, G. Luurtsema, W. E. Hennink, T. Beumer, A. H. P. Paes, H. G. M. Leufkens, C. Oussoren, R. J. Boskma, Peter W. Swaan, Nicolien Wieringa, de Dick Zeeuw, D. A. Bloemhof, B. Mevboom-de Jong, Ellis J. C. Boerkamp, K. J. C. Wientjes, G. Th. van der Werf, J. M. L. Engelen, E. R. Heerdink, J. E. Leysen, Anthonius de Boer, Inge H. Reuvers, D. de Boer, Yechiel A. Hekster, Auke Bult, Ron M. C. Herings, M. C. Cornel, C. Thomas, H. N. Magnani, P. M. L. A. Bemt, A. Schotte, H. A. Tissot van Patot, L. Veehof, E. C. A. Winden, Andrew Herxheimer, D. Shochat, D. Post, B. Struska, Harry Meinardi, P. H. Elsinga, H. Bloemhof, E. Postma-Lim, G. J. Driessen, R. M. E. Franssen, Donald R. A. Uges, J. H. Proost, Jennifer Heijman, J. Dijk, Arnold B. Bakker, L. M. L. Slolk, D. M. Barends, Henk Vos, J. C. Verhoef, Eric J. F. Franssen, Jenny Hettelaar, J. A. Leusink, Y. M. Groot-Padberg, M. J. Steenbergen, Margot Jeronimus-Stratingh, A. G. Rauws, H. G. A. Mokkink, L. E. Visser, L. Flendrig, W.H.M. Craane-van Hinsberg, H. R. M. Gorissen, M. Danhof, Eric J. C. Blok, P. Denig, L. T. W. Jong-van den Berg, P. F. M. Janssen, Hugo Paauw, F. J. Schmidt, H. Vromans, M. Foets, F. v. Dinther, T. F. J. Tromp, H. J. C. Wit, Cf Lerk, E. W. Massey, J. Fennis, E. W. M. Schrijnemakers, P. J. Swart, Miriam C. J. M. Sturkenboom, J. H. Beijnen, Jan I. Jmker, B. M. Jongh, W. Vaalburg, Eibert R. Heerdink, Flora M. Haaijer-Ruskamp, Daan J.A. Crommelin, M. Haas, F. W. J. Gribnau, B. J. Smit, J. J. H. Thijssen, M. Kuipers, Michiel H. De Vries, J. Raemaekers, C. E. M. Gelderen, F. W. Dijkers, A. M. Nijenhuis, Hubert G. Leufkens, Hans Kaldeway, Andries Bruins, D. K. F. Meijer, Miriam Mol, J. J. Tukker, Alma Middeibeek, John Urquhart, F. M. Haaijer-Ruskamp, Jan C. Reuyl, J. N. Davis, M. K. Casparie, M. H. Vingerhoeds, Floor Rikken, A. A. T. M. M. Vinks, A. Keyser, Jaap Willems, Lolkje T. W. de Jong-van den Berg, Albert Versluis, P. M. J. Stuvt, J. E. Nagtegaal, M. W. A. Jonge, J. M. K. H. Wierda, E. F. Smit, B. H. Ch. Stricker, Arijan J. Porsius, J. C. H. Borchert, J. W. Gubbels, S. W. F. Omta, G. L. Scherphof, H. Lier, K. Wiedhaup, D. K. F. Mijer, Max Maas, Jan W. Kijne, F. Iren, A. Kuijpers, J. Meulenbelt, H. G. M. Heijerman, Willy O. Renier, P. J. M. Kil, Jrbj Brouwers, E. T. J. Peters, Dick F. J. Tromp, Wim Vaalburg, Geb Visser, Lolkie T. W. Jong vd Berg, M. C. J. M. Sturkenboom, Gert Luurtsema, W. Bakker, C. Florax

Publikováno v: Pharmacy World & Science. 15:K3-K22

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::3346ebf853492dbe6eebd7b7908d9200
https://doi.org/10.1007/bf01870970

Urgent therapy for stroke. Part II. Pilot study of tissue plasminogen activator administered 91-180 minutes from onset

Autor: James C. Torner, M. C. W. Wong, E. C. Haley, T. G. Brott, J. R. Marler, George L. Sheppard, D. E. Levy, Gail L. Kongable

Publikováno v: Stroke. 23:641-645

Renewed interest in thrombolytic therapy as potential treatment for patients with acute ischemic stroke prompted a dose-escalation safety study of tissue plasminogen activator in patients with very early (less than or equal to 90 minutes; see Part I)

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::12ff24ab29a900f4913186a02d8a9c99
https://doi.org/10.1161/01.str.23.5.641

Does the National Institutes of Health Stroke Scale favor left hemisphere strokes? NINDS t-PA Stroke Study Group

Autor: D, Woo, J P, Broderick, R U, Kothari, M, Lu, T, Brott, P D, Lyden, J R, Marler, J C, Grotta

Publikováno v: Stroke. 30(11)

The National Institutes of Health Stroke Scale (NIHSS) is a valid, reproducible scale that measures neurological deficit. Of 42 possible points, 7 points are directly related to measurement of language compared with only 2 points related to neglect.W

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::71d9f98776854db23a580202f9c39c77
https://pubmed.ncbi.nlm.nih.gov/10548670

Effects of tissue plasminogen activator for acute ischemic stroke at one year. National Institute of Neurological Disorders and Stroke Recombinant Tissue Plasminogen Activator Stroke Study Group

Autor: T G, Kwiatkowski, R B, Libman, M, Frankel, B C, Tilley, L B, Morgenstern, M, Lu, J P, Broderick, C A, Lewandowski, J R, Marler, S R, Levine, T, Brott

Publikováno v: The New England journal of medicine. 340(23)

In 1995, the two-part National Institute of Neurological Disorders and Stroke (NINDS) Recombinant Tissue Plasminogen Activator Stroke Trial found that patients who were treated with tissue plasminogen activator (t-PA) within three hours after the ons

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::1a0130fb3c4bbfa1b67817daf0e9aa93
https://pubmed.ncbi.nlm.nih.gov/10523162

Urgent therapy for acute stroke. Effects of a stroke trial on untreated patients

Autor: William G. Barsan, D E Levy, Joseph P. Broderick, Thomas Brott, J R Marler, E C Haley

Publikováno v: Stroke. 25(11)

As part of the recruitment efforts for the National Institutes of Health Tissue Plasminogen Activator Pilot Study, public education and awareness campaigns were conducted to encourage early hospital arrival. We evaluated the change in arrival times d

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::16f8e8663ec1c781545ef45e3c255286
https://pubmed.ncbi.nlm.nih.gov/7974533